17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group (Q74239949)
Jump to navigation
Jump to search
scientific article published on 01 January 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group |
scientific article published on 01 January 2001 |
Statements
17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group (English)
N Bown
M Lastowska
S Cotterill
S O'Neill
C Ellershaw
P Roberts
I Lewis
A D Pearson
U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group